BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1677911)

  • 1. How to decrease bone marrow collection volume and risk contaminations via the operating room cell concentration?
    Grimaud Y; Sicre de Fontbrune F; Michonneau D; Desnoyer A; Peffault de Latour R; Larghero J; Nasone J; Faivre L
    Bone Marrow Transplant; 2024 May; 59(5):711-713. PubMed ID: 38418622
    [No Abstract]   [Full Text] [Related]  

  • 2. A technique for isolation of bone marrow cells using hydroxyethyl starch (HES) sedimentation agent.
    Montuoro A; De Rosa L; Del Monte C; Blandino F; Pandolfi A; Lanti T; De Laurenzi A
    Haematologica; 1991 Mar; 76 Suppl 1():7-9. PubMed ID: 1713876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiautomated autologous bone marrow processing for transplantation.
    Pierelli L; Menichella G; Paoloni A; Serafini R; Vittori M; Foddai ML; Meoni F; Rossi PL; Leone G; Mango G
    Haematologica; 1991 Mar; 76 Suppl 1():10-1. PubMed ID: 1677909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for large scale bone marrow hemopoietic stem cell manipulation.
    Menichella G; Pierelli L; Vittori M; Paoloni A; Foddai ML; Serafini R; Iacone A; Mango G
    Haematologica; 1991 Mar; 76 Suppl 1():3-6. PubMed ID: 1677911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood bank as a source of hematopoietic stem cells.
    Lasky LC
    Prog Clin Biol Res; 1986; 211():199-225. PubMed ID: 3515360
    [No Abstract]   [Full Text] [Related]  

  • 8. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
    Michallet M; Dhedin N; Michallet AS
    Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.